Advisory panel backs Galleri blood test for adults 50+, citing strong specificity, mixed sensitivity, and follow-up impacts as FDA weighs approval.
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Zabilugene Almadenorepvec Plus Chemo Shows Survival Gains in Metastatic PDAC
2
Telehealth May Offer a Path to More Equitable Myeloma Transplant Access
3
Giredestrant Plus Everolimus Improves PFS in ER+ Advanced Breast Cancer
4
In CML, Future Directions Include TKI Sequencing Strategies and Mutational Profiles
5